Comments
Natco Pharma’s consolidated net profit declined 52 per cent to Rs 14.34 crore in the third quarter ended December 31, 2014 compared with Rs 30 crore in the corresponding quarter of the previous financial year.
Total revenue of the Hyderabad-based company too declined to Rs 195 crore from Rs 203 crore.
The board of directors of the company has recommended payment of an interim dividend of Rs 5 per equity share of Rs 10 each for the year 2014-2015, the company informed the Bombay Stock Exchange on Wednesday.
Natco’s scrip declined 0.22 per cent on the BSE on Wednesday to end at Rs 1,431.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.